Clinical Trial Update: Sphingosine-1-phosphate and Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update involving sphingosine-1-phosphate for bacterial pneumonia with Phase 2 and Phase 3 exploration; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Pneumonia

Drugs mentioned

• Sphingosine-1-phosphate

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: Pneumonia, Bacterial | Phase 2, Phase 3 | Status: UNKNOWN